244 related articles for article (PubMed ID: 32627929)
1. D1 receptor-mediated endogenous tPA upregulation contributes to blood-brain barrier injury after acute ischaemic stroke.
Wang Y; Wang X; Zhang X; Chen S; Sun Y; Liu W; Jin X; Zheng G
J Cell Mol Med; 2020 Aug; 24(16):9255-9266. PubMed ID: 32627929
[TBL] [Abstract][Full Text] [Related]
2. Role of NADPH Oxidase-Induced Hypoxia-Induced Factor-1
Wang Y; Shen Y; Yu X; Gu J; Zhang X; Zhou B; Sun Y; Xu C; Qian S
Neural Plast; 2021; 2021():9928232. PubMed ID: 34434231
[TBL] [Abstract][Full Text] [Related]
3. Regulatory T cells ameliorate tissue plasminogen activator-induced brain haemorrhage after stroke.
Mao L; Li P; Zhu W; Cai W; Liu Z; Wang Y; Luo W; Stetler RA; Leak RK; Yu W; Gao Y; Chen J; Chen G; Hu X
Brain; 2017 Jul; 140(7):1914-1931. PubMed ID: 28535201
[TBL] [Abstract][Full Text] [Related]
4. Normobaric hyperoxia slows blood-brain barrier damage and expands the therapeutic time window for tissue-type plasminogen activator treatment in cerebral ischemia.
Liang J; Qi Z; Liu W; Wang P; Shi W; Dong W; Ji X; Luo Y; Liu KJ
Stroke; 2015 May; 46(5):1344-1351. PubMed ID: 25804925
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of HIF-1α Reduced Blood Brain Barrier Damage by Regulating MMP-2 and VEGF During Acute Cerebral Ischemia.
Shen Y; Gu J; Liu Z; Xu C; Qian S; Zhang X; Zhou B; Guan Q; Sun Y; Wang Y; Jin X
Front Cell Neurosci; 2018; 12():288. PubMed ID: 30233326
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylated recombinant HSP27 protects the brain and attenuates blood-brain barrier disruption following stroke in mice receiving intravenous tissue-plasminogen activator.
Shimada Y; Shimura H; Tanaka R; Yamashiro K; Koike M; Uchiyama Y; Urabe T; Hattori N
PLoS One; 2018; 13(5):e0198039. PubMed ID: 29795667
[TBL] [Abstract][Full Text] [Related]
7. β2-Adrenergic Receptor-Mediated HIF-1α Upregulation Mediates Blood Brain Barrier Damage in Acute Cerebral Ischemia.
Sun Y; Chen X; Zhang X; Shen X; Wang M; Wang X; Liu WC; Liu CF; Liu J; Liu W; Jin X
Front Mol Neurosci; 2017; 10():257. PubMed ID: 28855859
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of hypoxia inducible factor 1 by YC-1 attenuates tissue plasminogen activator induced hemorrhagic transformation by suppressing HMGB1/TLR4/NF-κB mediated neutrophil infiltration in thromboembolic stroke rats.
Kong L; Ma Y; Wang Z; Liu N; Ma G; Liu C; Shi R; Du G
Int Immunopharmacol; 2021 May; 94():107507. PubMed ID: 33657523
[TBL] [Abstract][Full Text] [Related]
9. Nicotine Treatment Ameliorates Blood-Brain Barrier Damage After Acute Ischemic Stroke by Regulating Endothelial Scaffolding Protein Pdlim5.
Hu X; Dong J; Geng P; Sun Y; Du W; Zhao X; Wang Q; Liu C; Wang X; Liu Y; Liu W; Cheng H; Wang W; Jin X
Transl Stroke Res; 2024 Jun; 15(3):672-687. PubMed ID: 37233908
[TBL] [Abstract][Full Text] [Related]
10. Bryostatin extends tPA time window to 6 h following middle cerebral artery occlusion in aged female rats.
Tan Z; Lucke-Wold BP; Logsdon AF; Turner RC; Tan C; Li X; Hongpaison J; Alkon DL; Simpkins JW; Rosen CL; Huber JD
Eur J Pharmacol; 2015 Oct; 764():404-412. PubMed ID: 26189021
[TBL] [Abstract][Full Text] [Related]
11. Recombinant tissue plasminogen activator induces blood-brain barrier breakdown by a matrix metalloproteinase-9-independent pathway after transient focal cerebral ischemia in mouse.
Copin JC; Bengualid DJ; Da Silva RF; Kargiotis O; Schaller K; Gasche Y
Eur J Neurosci; 2011 Oct; 34(7):1085-92. PubMed ID: 21895804
[TBL] [Abstract][Full Text] [Related]
12. NAD replenishment with nicotinamide mononucleotide protects blood-brain barrier integrity and attenuates delayed tissue plasminogen activator-induced haemorrhagic transformation after cerebral ischaemia.
Wei CC; Kong YY; Hua X; Li GQ; Zheng SL; Cheng MH; Wang P; Miao CY
Br J Pharmacol; 2017 Nov; 174(21):3823-3836. PubMed ID: 28812311
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant treatment with neuroserpin increases the therapeutic window for tissue-type plasminogen activator administration in a rat model of embolic stroke.
Zhang Z; Zhang L; Yepes M; Jiang Q; Li Q; Arniego P; Coleman TA; Lawrence DA; Chopp M
Circulation; 2002 Aug; 106(6):740-5. PubMed ID: 12163437
[TBL] [Abstract][Full Text] [Related]
14. Blood brain barrier breakdown was found in non-infarcted area after 2-h MCAO.
Wang X; Liu Y; Sun Y; Liu W; Jin X
J Neurol Sci; 2016 Apr; 363():63-8. PubMed ID: 27000223
[TBL] [Abstract][Full Text] [Related]
15. Microglial-mediated PDGF-CC activation increases cerebrovascular permeability during ischemic stroke.
Su EJ; Cao C; Fredriksson L; Nilsson I; Stefanitsch C; Stevenson TK; Zhao J; Ragsdale M; Sun YY; Yepes M; Kuan CY; Eriksson U; Strickland DK; Lawrence DA; Zhang L
Acta Neuropathol; 2017 Oct; 134(4):585-604. PubMed ID: 28725968
[TBL] [Abstract][Full Text] [Related]
16. Pinocembrin Protects Blood-Brain Barrier Function and Expands the Therapeutic Time Window for Tissue-Type Plasminogen Activator Treatment in a Rat Thromboembolic Stroke Model.
Ma Y; Li L; Kong L; Zhu Z; Zhang W; Song J; Chang J; Du G
Biomed Res Int; 2018; 2018():8943210. PubMed ID: 29850586
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cell-derived extracellular vesicles attenuate tPA-induced blood-brain barrier disruption in murine ischemic stroke models.
Qiu L; Cai Y; Geng Y; Yao X; Wang L; Cao H; Zhang X; Wu Q; Kong D; Ding D; Shi Y; Wang Y; Wu J
Acta Biomater; 2022 Dec; 154():424-442. PubMed ID: 36367475
[TBL] [Abstract][Full Text] [Related]
18. Ligustilide Ameliorates the Permeability of the Blood-Brain Barrier Model In Vitro During Oxygen-Glucose Deprivation Injury Through HIF/VEGF Pathway.
Wu S; Wang N; Li J; Wang G; Seto SW; Chang D; Liang H
J Cardiovasc Pharmacol; 2019 May; 73(5):316-325. PubMed ID: 30855407
[TBL] [Abstract][Full Text] [Related]
19. Potential molecular targets of peroxynitrite in mediating blood-brain barrier damage and haemorrhagic transformation in acute ischaemic stroke with delayed tissue plasminogen activator treatment.
Chen H; Chen X; Luo Y; Shen J
Free Radic Res; 2018 Dec; 52(11-12):1220-1239. PubMed ID: 30468092
[TBL] [Abstract][Full Text] [Related]
20. Role of Hypoxia Inducible Factor 1 in Hyperglycemia-Exacerbated Blood-Brain Barrier Disruption in Ischemic Stroke.
Zhang Z; Yan J; Shi H
Neurobiol Dis; 2016 Nov; 95():82-92. PubMed ID: 27425889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
